Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Novogrodsky

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1986
Anti-tumor properties of lymphocytes activated by the oxidizing mitogensJ Wang, M Suthanthiran, A Walle, et al.
The American Journal of Medicine|December 1, 1987
Adoptive immunotherapy for stage IV renal cell carcinoma: a novel protocol utilizing periodate and interleukin-2-activated autologous leukocytes and continuous infusions of low-dose interleukin-2J Wang, A Walle, B Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
A phase II clinical trial of adoptive immunotherapy for advanced renal cell carcinoma using mitogen-activated autologous leukocytes and continuous infusion interleukin-2J C Wang, A Walle, A Novogrodsky, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A cell line with unusual characteristics from an ovarian carcinoma patient: modulation of sensitivity to antitumour drugsL Wasserman, R Aviram, H Levavi, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|September 1, 1989
Altered expression of leucocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylationW L Greer, E Higgins, D R Sutherland, et al.
The Journal of Clinical Investigation|April 15, 1997
Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitisJ E Sevransky, G Shaked, A Novogrodsky, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1986
Anti-tumor properties of lymphocytes activated by the oxidizing mitogensJ Wang, M Suthanthiran, A Walle, et al.
The American Journal of Medicine|December 1, 1987
Adoptive immunotherapy for stage IV renal cell carcinoma: a novel protocol utilizing periodate and interleukin-2-activated autologous leukocytes and continuous infusions of low-dose interleukin-2J Wang, A Walle, B Gordon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
A phase II clinical trial of adoptive immunotherapy for advanced renal cell carcinoma using mitogen-activated autologous leukocytes and continuous infusion interleukin-2J C Wang, A Walle, A Novogrodsky, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A cell line with unusual characteristics from an ovarian carcinoma patient: modulation of sensitivity to antitumour drugsL Wasserman, R Aviram, H Levavi, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|September 1, 1989
Altered expression of leucocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylationW L Greer, E Higgins, D R Sutherland, et al.
The Journal of Clinical Investigation|April 15, 1997
Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitisJ E Sevransky, G Shaked, A Novogrodsky, et al.
Pageof 15